This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Wenfeng Xue
Introduction
Wenfeng Xue is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of potassium channel modulators. His work has implications for treating various diseases and disorders associated with potassium channels.
Latest Patents
Wenfeng Xue holds 1 patent for his invention titled "Crystalline forms of potassium channel modulators." This patent provides crystalline and amorphous forms of a compound with a specific structural formula. It also includes pharmaceutical compositions comprising these forms, methods for their manufacture, and their uses in treating a variety of conditions.
Career Highlights
Wenfeng Xue is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he focuses on innovative solutions for health challenges.
Collaborations
Wenfeng has collaborated with esteemed colleagues such as Gregg F. Keaney and Jun Xu. Their combined expertise contributes to the advancement of research in their field.
Conclusion
Wenfeng Xue's contributions to the field of potassium channel modulators highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile